Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rapamycin as a Potential Alternative Drug for Squamous Cell Gingiva Carcinoma (Ca9-22): A Focus on Cell Cycle, Apoptosis and Autophagy Genetic Profile. | Pharmaceuticals (Basel) | 2024 | 38276004 | PubTator, text mining | PubMed |
| SLCO4A1, as a novel prognostic biomarker of non‑small cell lung cancer, promotes cell proliferation and migration. | Int J Oncol | 2024 | 38275113 | PubTator, text mining | PubMed |
| Tonsillar cytotoxic CD4 T cells are involved in the control of EBV primary infection in children. | Sci Rep | 2024 | 38273012 | PubTator, text mining | PubMed |
| Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer Immunotherapy. | Molecules | 2024 | 38257366 | PubTator, text mining | PubMed |
| Epigenetic Dysregulation in the Pathogenesis of Systemic Lupus Erythematosus. | Int J Mol Sci | 2024 | 38256093 | PubTator, text mining | PubMed |
| Functional Characterization of Circadian Nuclear Receptors REV-ERBα and REV-ERBβ in Human Osteosarcoma Cell Cultures. | Int J Mol Sci | 2024 | 38255844 | PubTator, text mining | PubMed |
| New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3. | Vaccines (Basel) | 2024 | 38250867 | PubTator, text mining | PubMed |
| EGFR, HLA-G, CD70, c-MET, and NY-ESO1 as potential biomarkers in high grade epithelial ovarian carcinoma. | Cancer Biomark | 2024 | 38250760 | PubTator, text mining | PubMed |
| Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met? | Cells | 2024 | 38247837 | PubTator, text mining | PubMed |
| GLS and GOT2 as prognostic biomarkers associated with dendritic cell and immunotherapy response in breast cancer. | Heliyon | 2024 | 38234908 | PubTator, text mining | PubMed |
| Predictive value of peripheral blood biomarkers in patients with non-small-cell lung cancer responding to anti-PD-1-based treatment. | Cancer Immunol Immunother | 2024 | 38231411 | PubTator, text mining | PubMed |
| Zinc Transporters Serve as Prognostic Predictors and their Expression Correlates with Immune Cell Infiltration in Specific Cancer: A Pan-cancer Analysis. | J Cancer | 2024 | 38230214 | PubTator, text mining | PubMed |
| Prediction of immune infiltration and prognosis for patients with cholangiocarcinoma based on a cuproptosis-related lncRNA signature. | Heliyon | 2024 | 38226253 | PubTator, text mining | PubMed |
| Novel heterozygous mutations of TNFRSF13B in EBV-associated T/NK lymphoproliferative diseases (EBV-T/NK-LPDs). | Blood Sci | 2024 | 38226020 | PubTator, text mining | PubMed |
| Cancer vaccines: from an immunology perspective. | Immunother Adv | 2024 | 38223410 | PubTator, text mining | PubMed |
| TSCRE: a comprehensive database for tumor-specific cis-regulatory elements. | NAR Cancer | 2024 | 38213995 | PubTator, text mining | PubMed |
| Leveraging an immune cell signature to improve the survival and immunotherapy response of lung adenocarcinoma. | J Cancer | 2024 | 38213728 | PubTator, text mining | PubMed |
| Circular RNAs: Potential biomarkers and therapeutic targets for autoimmune diseases. | Heliyon | 2024 | 38205329 | PubTator, text mining | PubMed |
| Integrative Analyses of Pyrimidine Salvage Pathway-Related Genes Revealing the Associations Between UPP1 and Tumor Microenvironment. | J Inflamm Res | 2024 | 38204987 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer: A Review of Current Evidence. | Cells | 2024 | 38201305 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=16